[Central serous chorioretinopathy and systemic diseases report of 2 cases associated with corticotherapy]

Rev Med Interne. 2006 Jun;27(6):487-91. doi: 10.1016/j.revmed.2006.03.006. Epub 2006 Apr 6.
[Article in French]

Abstract

Introduction: Central serous chorioretinopathy is an uncommon retinal disease, whose pathogenesis is largely unknown. It is characterized by an accumulation of subretinal fluid at the posterior pole of the fundus, creating a circumscribed area of serous retinal detachment. It manifests generally as a visual loss or an abnormal colour vision. It is often idiopathic but may also be associated with numerous pathological situations, with frequent exposure to corticosteroids.

Exegesis: We report on two patients with central serous chorioretinopathy. The first female patient had been treated with steroids for a systemic lupus erythematosus for fifteen years, and the second male patient had been treated with steroids for an idiopathic hypereosinophilic syndrome for a few months. Visual loss led to a diagnosis of central serous chorioretinopathy. Lowering of steroids doses was followed by a clinical improvement in both cases.

Conclusion: Similarly to cataract or glaucoma, central serous chorioretinopathy belongs to the potential ocular side-effect of steroid treatment, and thus deserves to be known by internists.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / adverse effects*
  • Adult
  • Anti-Inflammatory Agents / adverse effects*
  • Chorioretinitis / chemically induced*
  • Chorioretinitis / diagnosis
  • Female
  • Humans
  • Hypereosinophilic Syndrome / complications*
  • Hypereosinophilic Syndrome / drug therapy
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Male
  • Retinal Detachment / chemically induced
  • Time Factors
  • Visual Acuity

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents